Inside Access, Outside the Rules
Two federal cases highlight alleged misuse of professional roles in health care settings
By
Kerri Miller
April 1, 2026
Clinical Scorecard: Inside Access, Outside the Rules
At a Glance
Category Detail
Condition Pharmacy Diversion Risk and Telemedicine Fraud Key Mechanisms Illegal acquisition of controlled substances and fraudulent Medicare billing practices. Target Population Pharmacists and telemedicine patients, particularly Medicare beneficiaries. Care Setting Pharmacy and telemedicine environments.
Key Highlights
Pharmacist indicted for diverting controlled substances from employer. Telemedicine company owner pleads guilty to $46M Medicare fraud scheme. Fraudulent practices included patient recruitment and billing for unnecessary items. Indicted individuals presumed innocent until proven guilty. Regulatory tensions highlighted in telemedicine oversight. Guideline-Based Recommendations
Diagnosis
Monitor for signs of substance diversion in pharmacy settings. Assess telemedicine practices for compliance with regulations. Management
Implement strict controls and audits in pharmacies handling controlled substances. Enhance oversight of telemedicine billing practices. Monitoring & Follow-up
Regularly review pharmacy operations for potential diversion risks. Conduct audits of telemedicine claims and patient interactions. Risks
Potential for substance abuse and legal repercussions for pharmacists. Financial and legal risks associated with fraudulent billing in telemedicine. Patient & Prescribing Data
Medicare beneficiaries and patients receiving controlled substances.
Patients may be subjected to unnecessary treatments or prescriptions due to fraudulent practices.
Clinical Best Practices
Establish clear protocols for handling controlled substances in pharmacies. Ensure meaningful patient-physician interactions in telemedicine. References
